Devices and methods for preparing pharmaceutical solutions

• US 5,196,001 A
• Filed: 03/05/1991
• Issued: 03/23/1993
• Est. Priority Date: 03/05/1991
• Status: Expired due to Fees

• Current Assignee: Ti Kao
• Original Assignee: Ti Kao
• Inventors: Kao, Ti
• Primary Examiner(s): Millin, V.
• Assistant Examiner(s): WONG, STEVEN B
• Application Number:
  US07/664,773
• Time in Patent Office: 749 Days
• Field of Search: 206/219, 206/438, 604/410, 604/416, 604/404, 604/403, 604/408, 604/409, 604/411, 604/415, 604/82, 604/86, 604/87, 34/240
• US Class Current: 604/416
• CPC Class Codes: A61J 1/10 Bag-type containers
• CPC Class Codes: A61J 1/2027 having frangible parts
• CPC Class Codes: A61J 1/2086 for fluid filtration
• CPC Class Codes: A61J 1/2093 Containers having several compartments for products to be mixed

Abstract

A device for the preparation of sterile U.S.P. pharmaceutical solutions for intravenous use includes a transparent first bag, a transparent second bag, and a filtration unit. The filtration unit has an inlet tube and an outlet tube, the inlet tube of the filtration unit being attached to an outlet port in the first bag and the outlet tube being connected to the second bag. The first bag has a resealable inlet port through which aqueous U.S.P. solvent and unit dose holders containing medicaments may be introduced. The unit dose holders which contain ingredients to be mixed with a solvent have air-filled portions separated from ingredient containing portions by a rupturable plastic portion. The contents of the holder may be released by manipulation of the air-filled portions. The unit dose holders are labeled such that the labeling may be read through the transparent bag. The unit dose holders may be inserted in combinations within the first bag combined so that the combination of the unit dose holder ingredients can produce a near neutral pH solution when the medicaments are released into the aqueous U.S.P. solvent. The solutions produced in the first bag may then be filtered into the second bag and administered to a patient.

Claims

1. A device for the preparation of sterile pharmaceutical solutions comprising:

(a) a first bag having a transparent, flexible plastic lining that defines a chamber;

(b) an inlet port formed in the lining and leading to the chamber, the inlet port permitting the loading of a unit dose holder into the chamber and the admission of a solvent into the chamber;

(c) a cap which seals the first bag inlet port after the loading of a unit does holder within the chamber;

(d) an outlet port leading away from the chamber located in the lining beneath the inlet port;

(e) a unit dose holder located completely within the chamber;

(f) a filtration unit having a filter combination suitable for the filtration of bacteria and particulate matter and an inlet tube and an outlet tube, the inlet tube of the filtration unit being attached to the outlet port of the first bag; and

(g) a second bag having an inlet port and an outlet port, the inlet port of the second bag being attached to the outlet tube of the filtration unit, wherein a solution contained within the first bag may be forced through the filtration unit into the second bag to form a solution adapted for medical use.

2. The device of claim 1 wherein the unit dose holder is located completely within the first bag chamber and unconnected to the first bag and containing an ingredient adapted to from a specified pharmaceutical solution when combined with a solvent admitted into the chamber.

3. The device of claim 2 wherein the unit dose holder is fabricated of a transparent plastic material.

4. The device of claim 2 wherein the unit dose holder has two sections, an upper section and a lower section, which are releasably engaged with one another to form the ingredient-filled portion.

5. The device of claim 1 wherein the unit dose holder is dimensioned to fit through the inlet port so it may be introduced into the chamber, wherein the unit dose holder has a flexible, air-filled portion spaced above a rupturable membrane, and an ingredient-containing portion located beneath the membrane, the ingredient-containing portion further having an area of weakened material located beneath the membrane portion, wherein the rupturable membrane, and the area of weakened material are susceptible to rupture upon application of pressure to the air-filled portion, wherein pressure applied to the flexible air-filled portion will cause both the rupturing of the rupturable membrane and the rupturing of the area of weakened material thus causing an ingredient contained in the holder to be released into the chamber.

6. The device of claim 5 wherein the unit dose holder has a label identifying the ingredient contained therein on the air-filled portion.

7. The device of claim 1 further comprising a means for exerting positive pressure upon the chamber of the first bag to force the pharmaceutical solution from the first bag through the filtration unit and into the second bag.

8. The device of claim 7 wherein the means for exerting a positive pressure upon the chamber is a pair of rollers through which the first bag filled with solution is pulled.

9. The device of claim 1 further comprising a unit dose holder located completely within the second bag, unconnected to the second bag and containing an ingredient adapted to form a specified pharmaceutical solution when combined with a solution admitted into the second bag.

10. The device of claim 9 wherein the unit dose holder within the second bag contains an emergency unit dose of medicine.

11. The device of claim 9 wherein the unit dose holder has a flexible, air filled portion spaced above a rupturable membrane, and an ingredient-containing portion is located beneath the membrane, wherein pressure applied to the flexible air-filled portion will cause the contents of the holder to be released into the second bag.

12. The device of claim 11 wherein the unit dose holder has a label identifying the ingredient contained therein on the air-filled portion.

13. The device of claim 9 wherein the unit dose holder is fabricated of a transparent plastic material.

14. The device of claim 9 wherein the unit dose holder has two sections, an upper section and a lower section, which are releasably engaged with one another to form the ingredient-filled portion.

15. A device for the preparation of sterile pharmaceutical solutions comprising:

(a) a first bag having a transparent, flexible plastic lining that defines a chamber, a resealable inlet port formed in the lining and leading to the chamber, the inlet port allowing the admission of a solvent into the chamber and an outlet port leading away from the chamber located in the lining beneath the inlet port;

(b) a filtration unit having a filter combination suitable for the filtration of bacteria and particulate matter and an inlet tube and an outlet tube, the inlet tube of the filtration unit being attached to the outlet port of the first bag;

(c) a second bag having an inlet port and an outlet port, the inlet port of the second bag being attached to the outlet tube of the filtration unit, wherein a solution contained within the first bag may be forced through the filtration unit into the second bag to form a solution adapted for medical use; and

(d) a unit dose holder located completely within the first bag chamber unconnected to the first bag and containing an ingredient adapted to form a specified pharmaceutical solution when combined with a solvent admitted into the chamber, wherein the unit dose holder is dimensioned to fit through the inlet port so it may be introduced into the chamber, and the unit dose holder has a flexible, air-filled portion spaced above a rupturable membrane, and an ingredient-containing portion is located beneath the membrane, wherein pressure applied to the flexible air-filled portion will cause the contents of the holder to be released into the chamber, and wherein the unit dose holder ingredient-containing portion has an area of weakened material susceptible to rupture upon application of pressure to the air-filled portion.

16. A device for the preparation of sterile pharmaceutical solutions comprising:

(a) a first bag having a transparent, flexible plastic lining that defines a chamber, a resealable inlet port formed in the lining and leading to the chamber, the inlet port allowing the admission of a solvent into the chamber and an outlet port leading away from the chamber located in the lining beneath the inlet port;

(b) a filtration unit having a filter combination suitable for the filtration of bacteria and particulate matter and an inlet tube and an outlet tube, the inlet tube of the filtration unit being attached to the outlet port of the first bag;

(c) a second bag having an inlet port and an outlet port, the inlet port of the second bag being attached to the outlet tube of the filtration unit, wherein a solution contained within the first bag may be forced through the filtration unit into the second bag to form a solution adapted for medical use; and

(d) a unit dose holder located completely within the second bag, unconnected to the second bag and containing an ingredient adapted to form a specified pharmaceutical solution when combined with a solution admitted into the second bag, wherein the unit dose holder has a flexible, air-filled portion spaced above a rupturable membrane, and an ingredient-containing portion is located beneath the membrane, wherein pressure applied to the flexible air-filled portion will cause the contents of the holder to be released into the second bag, and wherein the unit dose holder ingredient-containing portion has an area of weakened material susceptible to rupture upon application of pressure to the air-filled portion.

17. A buoyant unit dose holder for use within a device for preparing sterile pharmaceuticals having a bag formed of substantially transparent flexible material, the holder comprising:

(a) a first compartment containing air, the air containing compartment adapted to buoyantly suspend the holder within a liquid contained in the device bag;

(b) a second compartment which contains a medicament;

(c) located between the first compartment and the second compartment; and

(d) portions of the second compartment which define a line of weakened material which surrounds a rupturable bottom wall beneath the first compartment and forming the bottom of the second compartment, wherein upon application of pressure to the air-filled first compartment through the device bag, the medicament contained in the second compartment is released into the bag of the device.

18. The unit dose holder of claim 17 wherein the unit dose holder has a label identifying the ingredient contained therein on the air-filled first compartment.

19. The unit dose holder of claim 17 wherein the unit dose holder has two sections, an upper section and a lower section, which are releasably engaged with one another to define the second compartment and to contain the medicament therein.

20. A unit dose holder for use in a device for preparing sterile pharmaceuticals formed of substantially transparent flexible material, comprising:

(a) a first compartment containing air and a second compartment adapted to contain an ingredient, the first and second compartments being separated by a flexible collapsible wall, the second compartment further having an area of weakened material susceptible to rupture upon application of pressure to the air-filled first compartment wherein, upon application of pressure to the first compartment, an ingredient contained in the second compartment will be released into the device; and

(b) an pH indicator located within the second compartment.

21. A method for preparing sterile pharmaceutical solutions utilizing a device having a first bag having a resealable inlet port and a cap for sealing the inlet port and connected to a filtration unit which is connected to a second bag, comprising the steps of:

(a) inserting a holder of a sterile unit dose of a substance through the inlet port into the first bag of the device using aseptic techniques;

(b) adding sterile fluid through the inlet port into the first bag of the device using aseptic techniques;

(c) sealing the inlet port of the device with the cap;

(d) manipulating the first bag of the device to release the substance into the sterile fluid;

(e) manipulating the first bag of the device to mix the substance, and the sterile fluid to form a solution; and

(f) forcing the solution through the filtration unit into the second bag of the device.

22. The method of claim 21 comprising the further step of testing the pH after mixing the solution by inserting a pH testing dose holder containing a pH indicator through the inlet port and into the first bag, resealing the entry port with the cap, manipulating the pH testing dose holder so that the solution contacts the pH testing indicator and adding further ingredients to bring the pH to a desired level.

23. A method for preparing sterile pharmaceutical solutions utilizing a device having a first bag having an inlet port and a cap for sealing the inlet port, wherein the first bag is connected to a filtration unit which is connected to a second bag, comprising the steps of:

(a) inserting a first holder of a sterile unit dose of a first substance through the inlet port into the first bag of the device using aseptic techniques;

(b) inserting a second sterile holder of a unit dose of a second substance through the inlet port into the first bag of the device using aseptic techniques;

(c) adding sterile fluid through the inlet port into the first bag of the device using aseptic techniques;

(d) sealing the entry port of the device with the cap;

e) manipulating the first bag of the device to release the first substance and second substance into the sterile fluid;

f) manipulating the first bag of the device to mix the first substance, the second substance and the sterile fluid to form a solution; and

g) forcing the solution through the filtration unit into the second bag of the device.

24. The method of claim 23 wherein the second substance is an appropriate buffering agent for the first substance.

25. The method of claim 23 wherein the second substance is an appropriate neutralizing agent for the first substance.

26. The method of claim 23 wherein the first substance is dextrose and the second substance is sodium bicarbonate.